Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Decreases By 57.3%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totaling 9,188 shares, a drop of 57.3% from the December 31st total of 21,517 shares. Based on an average trading volume of 29,690 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.7% of the company’s stock are short sold. Currently, 0.7% of the company’s stock are short sold. Based on an average trading volume of 29,690 shares, the days-to-cover ratio is presently 0.3 days.

Arcadia Biosciences Trading Down 2.4%

NASDAQ:RKDA traded down $0.05 during mid-day trading on Friday, reaching $2.05. 10,149 shares of the stock were exchanged, compared to its average volume of 29,687. Arcadia Biosciences has a 1-year low of $1.76 and a 1-year high of $6.71. The firm has a market capitalization of $2.81 million, a PE ratio of 0.81 and a beta of 0.57. The business has a fifty day moving average price of $2.95 and a 200 day moving average price of $3.60.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings results on Friday, November 7th. The basic materials company reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.54) by $1.16. Arcadia Biosciences had a negative net margin of 97.97% and a negative return on equity of 8.80%. The business had revenue of $1.30 million for the quarter, compared to the consensus estimate of $1.90 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Arcadia Biosciences presently has an average rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.